CIK 0001133416 · Non-accelerated filer<br>Smaller reporting company
GALECTIN THERAPEUTICS INC
Sign in to watch- Ticker
- GALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 043562325
- Phone
- 678-620-3186
- Business address
- 4960 PEACHTREE INDUSTRIAL BOULEVARD, SUITE 240, NORCROSS, GA, 30071
- Former names
- PRO PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-08 | Shlevin Harold H. Director | Option exercise 10b5-1 | +20,000 | $1.98 | $40K | 31,206 |
| 2025-12-08 | Shlevin Harold H. Director | Sale 10b5-1 | −20,000 | $5.96 | $119K | 11,206 |
| 2025-12-08 | Shlevin Harold H. Director | Option exercise 10b5-1 | +25,000 | $1.72 | $43K | 36,206 |
| 2025-12-08 | Shlevin Harold H. Director | Sale 10b5-1 | −25,000 | $5.95 | $149K | 11,206 |
| 2025-12-08 | Shlevin Harold H. Director | Option exercise 10b5-1 | +35,000 | $2.11 | $74K | 46,206 |
| 2025-12-08 | Shlevin Harold H. Director | Sale 10b5-1 | −35,000 | $6.02 | $211K | 11,206 |
| 2025-12-08 | Shlevin Harold H. Director | Option exercise 10b5-1 | +20,000 | $1.11 | $22K | 31,206 |
| 2025-12-08 | Shlevin Harold H. Director | Sale 10b5-1 | −20,000 | $6.00 | $120K | 11,206 |
| 2025-12-08 | Shlevin Harold H. Director | Option exercise · Stock option (right to buy) 10b5-1 | −35,000 | 35,000 | ||
| 2025-12-08 | Shlevin Harold H. Director | Option exercise · Stock option (right to buy) 10b5-1 | −20,000 | 20,000 | ||
| 2025-12-08 | Shlevin Harold H. Director | Option exercise · Stock option (right to buy) 10b5-1 | −20,000 | 20,000 | ||
| 2025-12-08 | Shlevin Harold H. Director | Option exercise · Stock Option (right to buy) 10b5-1 | −25,000 | 25,000 | ||
| 2025-12-08 | Shlevin Harold H. Director | Option exercise · Stock Option (right to buy) 10b5-1 | −35,000 | 35,000 | ||
| 2025-12-08 | Shlevin Harold H. Director | Option exercise · Stock Option (right to buy) 10b5-1 | −20,000 | 20,000 | ||
| 2025-12-03 | 10X Fund, L.P. 10% owner | Sale | −132,069 | $5.73 | $757K | 5,670,138 |
| 2025-12-03 | 10X Fund, L.P. 10% owner | Sale | −120,000 | $5.73 | $688K | 5,682,207 |
| 2025-12-02 | 10X Fund, L.P. 10% owner | Sale | −30,000 | $5.47 | $164K | 5,802,207 |
| 2025-12-02 | 10X Fund, L.P. 10% owner | Sale | −30,000 | $5.47 | $164K | 5,802,207 |
| 2025-11-24 | 10X Fund, L.P. 10% owner | Other disposition | −24,000 | 5,645,138 | ||
| 2025-11-18 | LEWIS JOEL President and CEO | Option exercise 10b5-1 | +6,783 | $2.39 | $16K | 839,375 |
Page 6 of 15 · 291 trades